PMSI supports Onebright’s acquisition of Psicon

Onebright, the UK’s largest private outpatient mental healthcare company, significantly expands its neurodevelopmental services with the acquisition of Psicon Ltd.

Onebright provides a comprehensive range of market leading mental healthcare services, including neurodevelopmental assessments, to its private medical insurance, corporate, and consumer clients. With the addition of Psicon, the mental healthcare company has increased its breadth and depth of capabilities in this important area.

Psicon is a leading and rapidly growing provider of neurodevelopmental assessments for Autism and ADHD, and works extensively with the NHS, as well as providing private assessments to the public. The organisation offers a full range of assessment and treatment services across the lifespan and is one of the largest providers of children’s neurodevelopmental services in the UK.

The two brands will operate independently with Psicon continuing to be led by Managing Director Dr Dan Simmonds. With the support of Onebright it will significantly invest in its operational and technology capabilities and continue its UK expansion to enable more people to benefit from its exceptional services.

The new enlarged group will employ over 500 staff delivering services remotely and from a growing number of face-to-face clinics. Its operational centres are in York, London and Canterbury.

PMSI provided CDD to support the transaction.

Onebright expands neurodevelopmental services with Psicon acquisition